Industry: Pharma & Healthcare
Published Date: 2024-01-08
Pages: 122 Pages
Report ld: 3009542
Request Sample
Customized Report
Insulin Preparation Market Size(US$)

CAGR 2024-2030
5.1%
Market Size,2030
USD 36,510
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin.
The global market for Insulin Preparation was estimated to be worth US$ 25780 million in 2023 and is forecast to a readjusted size of US$ 36510 million by 2030 with a CAGR of 5.1% during the forecast period 2024-2030
The Insulin Preparation market is driven by the escalating global prevalence of diabetes and the growing need for effective diabetes management solutions. Insulin, a critical hormone for regulating blood sugar levels, plays a pivotal role in treating both type 1 and type 2 diabetes. The rise in diabetes cases, particularly due to sedentary lifestyles and unhealthy dietary habits, contributes to market growth as patients and healthcare providers seek reliable and accessible insulin preparations. Moreover, advancements in insulin delivery methods, such as pens, pumps, and inhalers, align with improved treatment convenience and adherence. However, the market also faces challenges, including the complexity of insulin dosing and administration, and the need for continuous patient education. Additionally, ensuring affordability and accessibility of insulin products, particularly in low-resource settings, and addressing potential adverse effects can pose obstacles for manufacturers. To succeed, companies must focus on patient-centric solutions, technological innovations in insulin delivery, and addressing the challenges to meet the increasing demand for safe and effective insulin preparations that enhance the quality of life for individuals living with diabetes.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Insulin Preparation, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Insulin Preparation by region & country, by Type, and by Application.
The Insulin Preparation market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Preparation.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Insulin Preparation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Insulin Preparation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Insulin Preparation in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Insulin Preparation Product Introduction
1.2 Global Insulin Preparation Market Size Forecast
1.2.1 Global Insulin Preparation Sales Value (2019-2030)
1.2.2 Global Insulin Preparation Sales Volume (2019-2030)
1.2.3 Global Insulin Preparation Sales Price (2019-2030)
1.3 Insulin Preparation Market Trends & Drivers
1.3.1 Insulin Preparation Industry Trends
1.3.2 Insulin Preparation Market Drivers & Opportunity
1.3.3 Insulin Preparation Market Challenges
1.3.4 Insulin Preparation Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Insulin Preparation Players Revenue Ranking (2023)
2.2 Global Insulin Preparation Revenue by Company (2019-2024)
2.3 Global Insulin Preparation Players Sales Volume Ranking (2023)
2.4 Global Insulin Preparation Sales Volume by Company Players (2019-2024)
2.5 Global Insulin Preparation Average Price by Company (2019-2024)
2.6 Key Manufacturers Insulin Preparation Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Insulin Preparation Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Insulin Preparation
2.9 Insulin Preparation Market Competitive Analysis
2.9.1 Insulin Preparation Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Insulin Preparation Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Preparation as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Fast-acting
3.1.2 Intermediate-acting
3.1.3 Long-acting
3.2 Global Insulin Preparation Sales Value by Type
3.2.1 Global Insulin Preparation Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Insulin Preparation Sales Value, by Type (2019-2030)
3.2.3 Global Insulin Preparation Sales Value, by Type (%) (2019-2030)
3.3 Global Insulin Preparation Sales Volume by Type
3.3.1 Global Insulin Preparation Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Insulin Preparation Sales Volume, by Type (2019-2030)
3.3.3 Global Insulin Preparation Sales Volume, by Type (%) (2019-2030)
3.4 Global Insulin Preparation Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital Pharmacy
4.1.2 Retail Pharmacy
4.1.3 Others
4.2 Global Insulin Preparation Sales Value by Application
4.2.1 Global Insulin Preparation Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Insulin Preparation Sales Value, by Application (2019-2030)
4.2.3 Global Insulin Preparation Sales Value, by Application (%) (2019-2030)
4.3 Global Insulin Preparation Sales Volume by Application
4.3.1 Global Insulin Preparation Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Insulin Preparation Sales Volume, by Application (2019-2030)
4.3.3 Global Insulin Preparation Sales Volume, by Application (%) (2019-2030)
4.4 Global Insulin Preparation Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Insulin Preparation Sales Value by Region
5.1.1 Global Insulin Preparation Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Insulin Preparation Sales Value by Region (2019-2024)
5.1.3 Global Insulin Preparation Sales Value by Region (2025-2030)
5.1.4 Global Insulin Preparation Sales Value by Region (%), (2019-2030)
5.2 Global Insulin Preparation Sales Volume by Region
5.2.1 Global Insulin Preparation Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Insulin Preparation Sales Volume by Region (2019-2024)
5.2.3 Global Insulin Preparation Sales Volume by Region (2025-2030)
5.2.4 Global Insulin Preparation Sales Volume by Region (%), (2019-2030)
5.3 Global Insulin Preparation Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Insulin Preparation Sales Value, 2019-2030
5.4.2 North America Insulin Preparation Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Insulin Preparation Sales Value, 2019-2030
5.5.2 Europe Insulin Preparation Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Insulin Preparation Sales Value, 2019-2030
5.6.2 Asia Pacific Insulin Preparation Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Insulin Preparation Sales Value, 2019-2030
5.7.2 South America Insulin Preparation Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Insulin Preparation Sales Value, 2019-2030
5.8.2 Middle East & Africa Insulin Preparation Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Insulin Preparation Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Insulin Preparation Sales Value
6.2.1 Key Countries/Regions Insulin Preparation Sales Value, 2019-2030
6.2.2 Key Countries/Regions Insulin Preparation Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Insulin Preparation Sales Value, 2019-2030
6.3.2 United States Insulin Preparation Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Insulin Preparation Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Insulin Preparation Sales Value, 2019-2030
6.4.2 Europe Insulin Preparation Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Insulin Preparation Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Insulin Preparation Sales Value, 2019-2030
6.5.2 China Insulin Preparation Sales Value by Type (%), 2023 VS 2030
6.5.3 China Insulin Preparation Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Insulin Preparation Sales Value, 2019-2030
6.6.2 Japan Insulin Preparation Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Insulin Preparation Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Insulin Preparation Sales Value, 2019-2030
6.7.2 South Korea Insulin Preparation Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Insulin Preparation Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Insulin Preparation Sales Value, 2019-2030
6.8.2 Southeast Asia Insulin Preparation Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Insulin Preparation Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Insulin Preparation Sales Value, 2019-2030
6.9.2 India Insulin Preparation Sales Value by Type (%), 2023 VS 2030
6.9.3 India Insulin Preparation Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Company Information
7.1.2 Novo Nordisk Introduction and Business Overview
7.1.3 Novo Nordisk Insulin Preparation Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Novo Nordisk Insulin Preparation Product Offerings
7.1.5 Novo Nordisk Recent Development
7.2 Sanofi-Aventis
7.2.1 Sanofi-Aventis Company Information
7.2.2 Sanofi-Aventis Introduction and Business Overview
7.2.3 Sanofi-Aventis Insulin Preparation Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Sanofi-Aventis Insulin Preparation Product Offerings
7.2.5 Sanofi-Aventis Recent Development
7.3 Eli Lilly
7.3.1 Eli Lilly Company Information
7.3.2 Eli Lilly Introduction and Business Overview
7.3.3 Eli Lilly Insulin Preparation Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Eli Lilly Insulin Preparation Product Offerings
7.3.5 Eli Lilly Recent Development
7.4 Tonghua Dongbao
7.4.1 Tonghua Dongbao Company Information
7.4.2 Tonghua Dongbao Introduction and Business Overview
7.4.3 Tonghua Dongbao Insulin Preparation Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Tonghua Dongbao Insulin Preparation Product Offerings
7.4.5 Tonghua Dongbao Recent Development
7.5 Ganlee
7.5.1 Ganlee Company Information
7.5.2 Ganlee Introduction and Business Overview
7.5.3 Ganlee Insulin Preparation Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Ganlee Insulin Preparation Product Offerings
7.5.5 Ganlee Recent Development
7.6 United Laboratory
7.6.1 United Laboratory Company Information
7.6.2 United Laboratory Introduction and Business Overview
7.6.3 United Laboratory Insulin Preparation Sales, Revenue and Gross Margin (2019-2024)
7.6.4 United Laboratory Insulin Preparation Product Offerings
7.6.5 United Laboratory Recent Development
7.7 Biocon
7.7.1 Biocon Company Information
7.7.2 Biocon Introduction and Business Overview
7.7.3 Biocon Insulin Preparation Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Biocon Insulin Preparation Product Offerings
7.7.5 Biocon Recent Development
7.8 Amphastar
7.8.1 Amphastar Company Information
7.8.2 Amphastar Introduction and Business Overview
7.8.3 Amphastar Insulin Preparation Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Amphastar Insulin Preparation Product Offerings
7.8.5 Amphastar Recent Development
7.9 Wockhardt
7.9.1 Wockhardt Company Information
7.9.2 Wockhardt Introduction and Business Overview
7.9.3 Wockhardt Insulin Preparation Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Wockhardt Insulin Preparation Product Offerings
7.9.5 Wockhardt Recent Development
7.10 Julphar Diabetes
7.10.1 Julphar Diabetes Company Information
7.10.2 Julphar Diabetes Introduction and Business Overview
7.10.3 Julphar Diabetes Insulin Preparation Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Julphar Diabetes Insulin Preparation Product Offerings
7.10.5 Julphar Diabetes Recent Development
8 Industry Chain Analysis
8.1 Insulin Preparation Industrial Chain
8.2 Insulin Preparation Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Insulin Preparation Sales Model
8.5.2 Sales Channel
8.5.3 Insulin Preparation Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Insulin Preparation was valued at US$ 27090 million in the year 2024 and is projected to reach a revised size of US$ 38190 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published Date: 2025-01-01
Pages: 86
USD 2900.00
(Single User License)
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin.
Published Date: 2024-04-12
Pages: 109
USD 4900.00
(Single User License)
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin.
Published Date: 2024-01-12
Pages: 89
USD 2900.00
(Single User License)
The global market for Insulin Preparation was valued at US$ 27090 million in the year 2024 and is projected to reach a revised size of US$ 38190 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published: 2025-01-01
Pages: 86
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin.
Published: 2024-04-12
Pages: 109
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin.
Published: 2024-01-12
Pages: 89
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now